Abstract
Purpose
To improve the gene delivery efficiency and safety of non-viral vector in liver cells, avidin, which exhibited good biocompatibility and remarkable accumulation in liver, was bioconjugated with biotinylated polyethylenimine to obtain a novel gene vector.
Materials and methods
Biotinylated polyethyleneimine/avidin bioconjugate (ABP) was synthesized through grafting biotin to high molecular weight branched polyethylenimine (PEI, 25 kDa) and then bioconjugating with avidin by the biotin-avidin interaction. Physiochemical characteristics of ABP/pDNA complexes were analyzed, and in vitro cytotoxicity and transfection of ABP were also evaluated in HepG2, Hela and 293 T cells by using 25 kDa PEI as the control.
Results
It was found that ABP was able to condense pDNA efficiently at N/P ratio of 4. The particle sizes of ABP/pDNA complexes were less than 220 nm, and the average surface charges were around 27 mV at the N/P ratio ranging from 2 to 60. Among three different cell lines, ABP and its DNA complexes demonstrated much lower cytotoxicity and higher transfection efficacy in HepG2 cells as compared with 25 kDa PEI.
Conclusion
ABP presented higher transfection efficacy and safety in HepG2 cells due to the biocompatibility of avidin and the specific interactions between avidin and HepG2 cells.
Similar content being viewed by others
References
Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–17.
Follenzi A, Gupta S. The promise of lentiviral gene therapy for liver cancer. J Hepatol. 2004;40:337–40.
Willhauck MJ, Sharif SBR, Klutz K, Cengic N, Wolf I, Mohr L, et al. α-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma. Gene Ther. 2007;15:214–23.
Sangro B, Herraiz M, Prieto J. Gene therapy of neoplastic liver diseases. Int J Biochem Cell Biol. 2003;35:135–48.
Schmitz V, Qian C, Ruiz J, Sangro B, Melero I, Mazzolini G. Gene therapy for liver diseases: recent strategies for treatment of viral hepatitis and liver malignancies. Gut. 2002;50:130–5.
Jiang HL, Kwon JT, Kim YK, Kim EM, Arote R, Jeong HJ, et al. Galactosylated chitosan-graft-polyethylenimine as a gene carrier for hepatocyte targeting. Gene Ther. 2007;14:1389–98.
Varga CM, Tedford NC, Thomas M, Klibanov AM, Griffith LG, Lauffenburger DA. Quantitative comparison of polyethylenimine. formulations and adenoviral vectors in terms of intracellular gene delivery processes. Gene Ther. 2005;12:1023–32.
Liu L, Zern MA, Lizarzaburu ME, Nantz MH, Wu J. Poly (cationic lipid)-mediated in vivo gene delivery to mouse liver. Gene Ther. 2003;10:180–7.
Li S, Huang L. Nonviral gene therapy: promises and challenges. Gene Ther. 2000;7:31–4.
Niidome T, Huang L. Gene therapy progress and prospects: nonviral vectors. Gene Ther. 2002;9:1647–52.
Kaneda Y, Tabata Y. Non-viral vectors for cancer therapy. Cancer Sci. 2006;97:348–54.
Bajaj A, Kondiah P, Bhattacharya S. Design, synthesis, and in vitro gene delivery efficacies of novel cholesterol-based gemini cationic lipids and their serum compatibility: a structure-activity investigation. J Med Chem. 2007;50:2432–42.
Bhattacharya S, Bajaj A. Fluorescence and thermotropic studies of the interactions of PEI-cholesterol based PEI-chol lipopolymers with dipalmitoyl phosphatidylcholine membranes. Biochim Biophys Acta Biomembranes. 2008;1778:2225–33.
Ahn HH, Lee JH, Kim KS, Lee JY, Kim MS, Khang G, et al. Polyethyleneimine-mediated gene delivery into human adipose derived stem cells. Biomaterials. 2008;29:2415–22.
Ahn CH, Chae SY, Bae YH, Kim SW. Biodegradable poly(ethylenimine) for plasmid DNA delivery. J Control Release. 2002;80:273–82.
Godbey WT, Wu KK, Mikos AG. Poly(ethylenimine) and its role in gene delivery. J Control Release. 1999;60:149–60.
Lungwitz U, Breunig M, Blunk T, Gopferich A. Polyethylenimine-based non-viral gene delivery systems. Eur J Pharm Biopharm. 2005;60:247–66.
Wightman L, Kircheis R, Rossler V, Carotta S, Ruzicka R, Kursa M, et al. Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J Gene Med. 2001;3:362–72.
Liang B, He ML, Xiao ZP, Li Y, Chan CY, Kung HF, et al. Synthesis and characterization of folate-PEG-grafted-hyperbranched-PEI for tumor-targeted gene delivery. Biochem Biophys Res Commun. 2008;367:874–80.
Wall DA, Hubbard AL. Receptor-mediated endocytosis of asialoglycoproteins by rat liver hepatocytes: biochemical characterization of the endosomal compartments. J Cell Biol. 1998;101:2104–12.
Li H, Qian ZM. Transferrin/transferrin receptor-mediated drug delivery. Med Res Rev. 2002;22:225–50.
Benns JM, Mahato RI, Kim SW. Optimization of factors influencing the transfection efficiency of folate-PEG-folate-graft-polyethylenimine. J Control Release. 2002;79:255–69.
Shigeta K, Kawakami S, Higuchi Y, Okuda T, Yagi H, Yamashita F, et al. Novel histidine-conjugated galactosylated cationic liposomes for efficient hepatocyte-selective gene transfer in human hepatoma HepG2 cells. J Control Release. 2007;118:262–70.
Elfinger M, Maucksch C, Rudolph C. Characterization of lactoferrin as a targeting ligand for nonviral gene delivery to airway epithelial cells. Biomaterials. 2007;28:3448–55.
Sun YX, Zeng X, Meng QF, Zhang XZ, Cheng SX, Zhuo RX. The influence of RGD addition on the gene transfer characteristics of disulfide-containing polyethyleneimine/DNA complexes. Biomaterials. 2008;29:4356–65.
Laitinen OH, Nordlund HR, Hytonen VP, Kulomaa MS. Brave new (strept) avidins in biotechnology. Trends Biotechnol. 2007;25:269–77.
Mamede M, Saga T, Ishimori T, Higashi T, Sato N, Kobayashi H, et al. Hepatocyte targeting of 111In-labeled oligo-DNA with avidin or avidin-dendrimer complex. J Control Release. 2004;95:133–41.
Sakahara H, Saga T. Avidin-biotin system for delivery of diagnostic agents. Adv Drug Deliv Rev. 1999;37:89–101.
Huang H, Oizumi S, Kojima N, Niino T, Sakai Y. Avidin-biotin binding-based cell seeding and perfusion culture of liver-derived cells in a porous scaffold with a three-dimensional interconnected flow-channel network. Biomaterials. 2007;28:3815–23.
Kim MS, Seo KS, Khang G, Lee HB. First preparation of biotinylated gradient polyethylene surface to bind photoactive caged streptavidin. Langmuir. 2005;21:4066–70.
DeLange RJ. Egg white avidin. I. Amino acid composition; sequence of the amino- and carboxyl-terminal cyanogen bromide peptides. J Biol Chem. 1970;245:907–16.
Schechter B, Silberman R, Arnon R, Wilchek M. Tissue distribution of avidin and streptavidin injected to mice. Eur J Biochem. 1990;189:327–31.
Chen L, Schechter B, Arnon R, Wilchek M. Tissue selective affinity targeting using the avidin-biotin system. Drug Develop Res. 2000;50:258–71.
Fumoto S, Kawakami S, Ito Y, Shigeta K, Yamashita F, Hashida M. Enhanced hepatocyte-selective in vivo gene expression by stabilized galactosylated liposome/plasmid DNA complex using sodium chloride for complex formation. Mol Ther. 2004;10:719–29.
Benns JM, Choi JS, Mahato RI, Park JS, Kim SW. pH-sensitive cationic polymer gene delivery vehicle: N-ac-poly(L-histidine)-graft-poly(L-lysine) comb shaped polymer. Bioconjug Chem. 2000;11:637–45.
Bajaj A, Kondaiah P, Bhattacharya S. Synthesis and gene transfection efficacies of PEI-Cholesterol-based lipopolymers. Bioconjugate Chem. 2008;19:1640–51.
Khandare J, Kolhe P, Pillai O, Kannan S, Lieh-Lai M, Kannan RM. Synthesis, cellular transport, and activity of polyamidoamine dendrimer-methylprednisolone conjugates. Bioconjug Chem. 2005;16:330–7.
Xu DM, Yao SD, Liu YB, Sheng KL, Hong J, Gong PJ, et al. Size-dependent properties of M-PEIs nanogels for gene delivery in cancer cells. Int J Pharm. 2007;338:291–96.
Hattori Y, Maitani Y. Low-molecular-weight polyethylenimine enhanced gene transfer by cationic cholesterol-based nanoparticle vector. Biol Pharm Bull. 2007;30:1773–8.
Putnam D, Gentry CA, Pack DW, Langer R. Polymer-based gene delivery with low cytotoxicity by a unique balance of side-chain termini. Proc Natl Acad Sci USA. 2001;98:1200–5.
Clamme JP, Azoulay J, Mely Y. Monitoring of the formation and dissociation of polyethylenimine/DNA complexes by two photon fluorescence correlation spectroscopy. Biophys J. 2003;84:1960–8.
Wojda U, Miller JL. Targeted transfer of polyethylenimine-avidin-DNA bioconjugates to hematopoietic cells using biotinylated monoclonal antibodies. J Pharm Sci. 2000;89:674–81.
Wojda U, Goldsmith P, Miller JL. Surface membrane biotinylation efficiently mediates the endocytosis of avidin bioconjugates into nucleated cells. Bioconjug Chem. 1999;10:1044–50.
Acknowledgement
Acknowledgement is made to National Natural Science Foundation of China (50633020), National Key Basic Research Program of China (2005CB623903) and Ministry of Education of China (Cultivation Fund of Key Scientific and Technical Innovation, Project 707043).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Zeng, X., Sun, YX., Zhang, XZ. et al. A Potential Targeting Gene Vector Based on Biotinylated Polyethyleneimine/Avidin Bioconjugates. Pharm Res 26, 1931–1941 (2009). https://doi.org/10.1007/s11095-009-9920-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-009-9920-4